Waystar's AI-Fueled Momentum Meets a CFO Transition
Q2 beats, guidance raised, and the autonomous revenue cycle narrative gets sharper even as the finance chief steps aside
WAY · Earnings Call · 2026-07-29
Introduction: Strong Q2 and Raised Guidance
Waystar Holding Corp. reported a solid second quarter, with revenue of $320 million (18% YoY), adjusted EBITDA of $137 million (43% margin), and a ninth consecutive quarter of beating consensus. The company raised its full-year revenue guidance by $2 million to a midpoint of $1.285 billion and its adjusted EBITDA midpoint by $5 million to $540 million. The numbers suggest momentum, but the more striking news is strategic: the CFO transition and an increasingly explicit AI-first narrative.
“We delivered another solid quarter as we executed our strategy, supported our clients and advanced the Waystar platform toward a more autonomous revenue cycle.” — Matthew Hawkins, Chief Executive Officer · 2026-07-29
AI and the Autonomous Revenue Cycle
Management's language around AI has sharpened. The new solutions and Waystar client cross-sell momentum were underscored by more than $6 million of bookings from existing clients purchasing Iodine capabilities—an early proof point of the financial-clinical data integration. Matt Hawkins emphasized that AI is not experimental:
Our AI deployment is not experimental. It is embedded and monetized, and it delivers meaningful outcomes inside the mission-critical workflows our clients rely on every day.
This is consistent with prior quarters, but the specificity has increased. The company highlighted a double-digit number of $1 million-plus ACV bookings, and a client win replacing three vendors across claims, patient financial care, clinical documentation integrity, and revenue capture. The system of action positioning is now paired with the Iodine integration to attack the mid-cycle and create the "perfect undeniable claim."
Volume-Based Revenue Normalization
A key storyline is the normalization of volume-based revenue. Subscription revenue grew 34% (12% organic), while volume-based revenue grew only 3%, but on a normalized basis excluding one-time items, it was approximately 8% YoY. Management reiterated that patient utilization is returning to the long-term 1–2% trend after elevated COVID-era levels. The print-to-digital transition within patient payments continues to weigh on gross volume-based growth, but it is margin-neutral. As Steve Oreskovich noted, “the patient utilization aligns with both our expectations and with overall guidance for the year.” — Steven Oreskovich, Chief Financial Officer · 2026-07-29
This dynamic is not new—it was flagged in prior calls, e.g., “It is primarily the conversion of print to digital statements and then also a little bit of the utilization of the health care system by patients.” — Matthew Hawkins, Chief Executive Officer · 2026-04-29 However, the company is now more confident in the shape of the recovery, and the guidance raise reflects that.
Leadership Transition and Strategic Positioning
The most surprising news was the CFO transition. Steve Oreskovich, who has been CFO for eight years, is stepping down and will be replaced by Alpana Wegner. The move adds uncertainty, but management framed it as a planned transition. Matt Hawkins praised Steve's contribution, and the new CFO brings public-company software experience.
The company also highlighted its expanding capitalized software investment—roughly doubling year-over-year in H1—to fund AI platform capabilities. This is a deliberate trade-off: while free cash flow conversion dipped to 47% due to tax timing, management is prioritizing long-term growth. The volume based business remains a volatile mix, but the overall revenue mix is shifting to higher-margin subscription and AI-enabled solutions.
Revenue rose 22% year-over-year to $314M in the quarter, with organic growth of 7% (or 10% normalized). The stock, still down ~45% from its February 2025 peak, has rebounded 16% over the last 90 days, suggesting investors are starting to buy the AI story.
In conclusion, Waystar is executing on its strategy, but the real change is the confidence with which it is articulating its AI roadmap and the leadership shake-up at the finance helm. The autonomous revenue cycle vision is becoming tangible, and the market is listening.